2,985 hedge funds and large institutions have $100B invested in Pfizer in 2024 Q4 according to their latest regulatory filings, with 378 funds opening new positions, 933 increasing their positions, 1,460 reducing their positions, and 245 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

8% less capital invested

Capital invested by funds: $109B → $100B (-$8.71B)

15% less call options, than puts

Call options by funds: $3.28B | Put options by funds: $3.87B

36% less repeat investments, than reductions

Existing positions increased: 933 | Existing positions reduced: 1,460

Holders
2,985
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
42
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.28B
Puts
$3.87B
Net Calls
Net Calls Change

Top Sellers

1 -$644M
2 -$337M
3 -$293M
4
JP Morgan Chase
JP Morgan Chase
New York
-$285M
5
Barclays
Barclays
United Kingdom
-$277M
Name Holding Trade Value Shares
Change
Change in
Stake
2651
$201K
2652
$200K
2653
$197K
2654
$193K
2655
$193K
2656
$191K
2657
$188K
2658
$187K
2659
$186K
2660
$186K
2661
$185K
2662
$184K
2663
$182K
2664
$180K
2665
$179K
2666
$178K
2667
$177K
2668
$175K
2669
$173K
2670
$172K
2671
$168K
2672
$168K
2673
$166K
2674
$164K
2675
$161K